Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Proflexa** is a marketed topical over-the-counter analgesic cream developed by Sinoveda. Its labeled active ingredient is natural camphor 3.3%, which provides temporary relief of minor muscle and joint aches associated with arthritis, simple backache, strains, sprains, and bruises. The cream also contains botanical ingredients including clove oil, safflower, angelica root, frankincense, myrrh, and Chuanxiong extracts; these are listed as inactive ingredients in the U.S. OTC label. Sinoveda markets the product as a standardized botanical formulation developed using its Pharmaceutical Platform Technology. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e9ebcd18-e229-78b0-e053-2995a90acd1f))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Proflexa.